H.R.5239 - Prescription Drug Price Reporting Act116th Congress (2019-2020)
|Sponsor:||Rep. Joyce, David P. [R-OH-14] (Introduced 11/21/2019)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 11/22/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.5239 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (11/21/2019)
Prescription Drug Price Reporting Act
This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.
HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.